DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Valgimigli M, Campo G, de Cesare N. et al.
, on behalf of Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Circulation 2009;
119: 3215-3222.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.